Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1573-2568
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B ; day:3 ; month:2 ; year:2023 ; pages:1-7
Digestive diseases and sciences ; (3.2.2023), 1-7

Urheber
Mateos-Muñoz, Beatriz
Buti, María
Vázquez, Inmaculada Fernández
Conde, Marta Hernández
Bernal-Monterde, Vanesa
Díaz-Fontenla, Fernando
Morillas, Rosa María
García-Buey, Luisa
Badía, Ester
Miquel, Mireia
Amador-Navarrete, Alberto
Rodríguez-Tajes, Sergio
Ramos-Merino, Lucía
Madejón, Antonio
García-Retortillo, Montserrat
Arenas, Juan Ignacio
Cabezas, Joaquín
Santiago, Jesús Manuel González
Fernández-Rodríguez, Conrado
Cordero, Patricia
Diago, Moisés
Mancebo, Antonio
Pardo, Alberto
Rodríguez, Manuel
Hoyas, Elena
Moreno, Jose Javier
Turnes, Juan
Simón, Miguel Ángel
Marcos-Fosch, Cristina
Calleja, Jose Luis
Bañares, Rafael
Lens, Sabela
Garcia-Samaniego, Javier
Crespo, Javier
Romero-Gomez, Manuel
Gea, Francisco
Santiago, Enrique Rodríguez de
Moreno, Santiago
Albillos, Agustin
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s10620-022-07817-w
URN
urn:nbn:de:101:1-2023040809102473626342
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:44 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Mateos-Muñoz, Beatriz
  • Buti, María
  • Vázquez, Inmaculada Fernández
  • Conde, Marta Hernández
  • Bernal-Monterde, Vanesa
  • Díaz-Fontenla, Fernando
  • Morillas, Rosa María
  • García-Buey, Luisa
  • Badía, Ester
  • Miquel, Mireia
  • Amador-Navarrete, Alberto
  • Rodríguez-Tajes, Sergio
  • Ramos-Merino, Lucía
  • Madejón, Antonio
  • García-Retortillo, Montserrat
  • Arenas, Juan Ignacio
  • Cabezas, Joaquín
  • Santiago, Jesús Manuel González
  • Fernández-Rodríguez, Conrado
  • Cordero, Patricia
  • Diago, Moisés
  • Mancebo, Antonio
  • Pardo, Alberto
  • Rodríguez, Manuel
  • Hoyas, Elena
  • Moreno, Jose Javier
  • Turnes, Juan
  • Simón, Miguel Ángel
  • Marcos-Fosch, Cristina
  • Calleja, Jose Luis
  • Bañares, Rafael
  • Lens, Sabela
  • Garcia-Samaniego, Javier
  • Crespo, Javier
  • Romero-Gomez, Manuel
  • Gea, Francisco
  • Santiago, Enrique Rodríguez de
  • Moreno, Santiago
  • Albillos, Agustin
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate

Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate

Clinical Results of Tenofovir Disoproxil Fumarate in a Hemodialysis Patient with Chronic Hepatitis B

Clinical Results of Tenofovir Disoproxil Fumarate in a Hemodialysis Patient with Chronic Hepatitis B

Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate in patients with Hepatitis B: a network meta-analysis

Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate in patients with Hepatitis B: a network meta-analysis

Effects of entecavir and tenofovir disoproxil fumarate on the incidence and severity of COVID-19 in patients with chronic hepatitis B

Effects of entecavir and tenofovir disoproxil fumarate on the incidence and severity of COVID-19 in patients with chronic hepatitis B

Effects of tenofovir alafenamide fumarate on serum lipid profiles in patients with chronic hepatitis B

Effects of tenofovir alafenamide fumarate on serum lipid profiles in patients with chronic hepatitis B

Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis

Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis

Chiral Analysis of the Key Intermediates of Tenofovir Alafenamide Fumarate

Chiral Analysis of the Key Intermediates of Tenofovir Alafenamide Fumarate

Real-World Single-Center Comparison of the Safety and Efficacy of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide in Patients with Chronic Hepatitis B

Real-World Single-Center Comparison of the Safety and Efficacy of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide in Patients with Chronic Hepatitis B

Renal function in Japanese HIV-1-positive patients who switch to tenofovir alafenamide fumarate after long-term tenofovir disoproxil fumarate: a single-center observational study

Renal function in Japanese HIV-1-positive patients who switch to tenofovir alafenamide fumarate after long-term tenofovir disoproxil fumarate: a single-center observational study

Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV

Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV

Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization

Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization

Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results

Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results

Verbundene Objekte